Cargando…
Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development
Advancement in novel target detection using improved molecular cancer biology has opened up new avenues for promising anti-cancer drug development. In the past two decades, the mechanism of tumor hypoxia has become more understandable with the discovery of hypoxia-inducible factor-1α (HIF-1α). It is...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413992/ https://www.ncbi.nlm.nih.gov/pubmed/36014432 http://dx.doi.org/10.3390/molecules27165192 |
_version_ | 1784775885515128832 |
---|---|
author | Ghosh, Rituparna Samanta, Priya Sarkar, Rupali Biswas, Souradeep Saha, Prosenjit Hajra, Subhadip Bhowmik, Arijit |
author_facet | Ghosh, Rituparna Samanta, Priya Sarkar, Rupali Biswas, Souradeep Saha, Prosenjit Hajra, Subhadip Bhowmik, Arijit |
author_sort | Ghosh, Rituparna |
collection | PubMed |
description | Advancement in novel target detection using improved molecular cancer biology has opened up new avenues for promising anti-cancer drug development. In the past two decades, the mechanism of tumor hypoxia has become more understandable with the discovery of hypoxia-inducible factor-1α (HIF-1α). It is a major transcriptional regulator that coordinates the activity of various transcription factors and their downstream molecules involved in tumorigenesis. HIF-1α not only plays a crucial role in the adaptation of tumor cells to hypoxia but also regulates different biological processes, including cell proliferation, survival, cellular metabolism, angiogenesis, metastasis, cancer stem cell maintenance, and propagation. Therefore, HIF-1α overexpression is strongly associated with poor prognosis in patients with different solid cancers. Hence, pharmacological targeting of HIF-1α has been considered to be a novel cancer therapeutic strategy in recent years. In this review, we provide brief descriptions of natural and synthetic compounds as HIF-1α inhibitors that have the potential to accelerate anticancer drug discovery. This review also introduces the mode of action of these compounds for a better understanding of the chemical leads, which could be useful as cancer therapeutics in the future. |
format | Online Article Text |
id | pubmed-9413992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94139922022-08-27 Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development Ghosh, Rituparna Samanta, Priya Sarkar, Rupali Biswas, Souradeep Saha, Prosenjit Hajra, Subhadip Bhowmik, Arijit Molecules Review Advancement in novel target detection using improved molecular cancer biology has opened up new avenues for promising anti-cancer drug development. In the past two decades, the mechanism of tumor hypoxia has become more understandable with the discovery of hypoxia-inducible factor-1α (HIF-1α). It is a major transcriptional regulator that coordinates the activity of various transcription factors and their downstream molecules involved in tumorigenesis. HIF-1α not only plays a crucial role in the adaptation of tumor cells to hypoxia but also regulates different biological processes, including cell proliferation, survival, cellular metabolism, angiogenesis, metastasis, cancer stem cell maintenance, and propagation. Therefore, HIF-1α overexpression is strongly associated with poor prognosis in patients with different solid cancers. Hence, pharmacological targeting of HIF-1α has been considered to be a novel cancer therapeutic strategy in recent years. In this review, we provide brief descriptions of natural and synthetic compounds as HIF-1α inhibitors that have the potential to accelerate anticancer drug discovery. This review also introduces the mode of action of these compounds for a better understanding of the chemical leads, which could be useful as cancer therapeutics in the future. MDPI 2022-08-15 /pmc/articles/PMC9413992/ /pubmed/36014432 http://dx.doi.org/10.3390/molecules27165192 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ghosh, Rituparna Samanta, Priya Sarkar, Rupali Biswas, Souradeep Saha, Prosenjit Hajra, Subhadip Bhowmik, Arijit Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development |
title | Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development |
title_full | Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development |
title_fullStr | Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development |
title_full_unstemmed | Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development |
title_short | Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development |
title_sort | targeting hif-1α by natural and synthetic compounds: a promising approach for anti-cancer therapeutics development |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413992/ https://www.ncbi.nlm.nih.gov/pubmed/36014432 http://dx.doi.org/10.3390/molecules27165192 |
work_keys_str_mv | AT ghoshrituparna targetinghif1abynaturalandsyntheticcompoundsapromisingapproachforanticancertherapeuticsdevelopment AT samantapriya targetinghif1abynaturalandsyntheticcompoundsapromisingapproachforanticancertherapeuticsdevelopment AT sarkarrupali targetinghif1abynaturalandsyntheticcompoundsapromisingapproachforanticancertherapeuticsdevelopment AT biswassouradeep targetinghif1abynaturalandsyntheticcompoundsapromisingapproachforanticancertherapeuticsdevelopment AT sahaprosenjit targetinghif1abynaturalandsyntheticcompoundsapromisingapproachforanticancertherapeuticsdevelopment AT hajrasubhadip targetinghif1abynaturalandsyntheticcompoundsapromisingapproachforanticancertherapeuticsdevelopment AT bhowmikarijit targetinghif1abynaturalandsyntheticcompoundsapromisingapproachforanticancertherapeuticsdevelopment |